Additionally, morning dosing may provide coverage during daytime meals when carbohydrate intake is typically higher
131 The direct impact of GLP-1 on these cells slows the secretion of glucagon, essential for maintaining glucose stability, especially postprandially
the precise combined metabolic effects of simultaneous GLP-1, GIP, and glucagon receptor activation in humans are still being characterised
Activation of GLP-1R induces an increase in intracellular Ca 2+ in 40% of NTS astrocytes, while selective inhibition of astrocyte function in NTS abolishes exendin-4-induced inhibition of food intake (Reiner et al., 2016)
Emerging treatment strategies for polycystic ovary syndrome women with obesity: focus on glucagon-like peptide-1 receptor agonists
GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms